VYGR - Voyager Therapeutics, Inc.
IEX Last Trade
5.69
0.010 0.176%
Share volume: 6,929
Last Updated: Fri 27 Dec 2024 08:30:02 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$5.68
0.01
0.18%
Summary score
25%
Profitability
25%
Dept financing
10%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-3.87%
Return on assets
-0.8%
Return on sales
-621.73%
Return on invested capital
113.85%
Total debt ratio
48.32%
Debt ratio change over timeo
-0.86%
Current Ratio
4.99%
Quick Ratio
4.99%
Cash Position Ratio
4.62%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-1.33%
Return on assets
-1.53%
Return on sales
-296.58%
Return on invested capital
49.05%
Total debt ratio
34.31%
Debt ratio change over timeo
-0.79%
Current Ratio
5.26%
Quick Ratio
5.26%
Cash Position Ratio
4.8%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-3.32%
Return on assets
-3.45%
Return on sales
-82.92%
Return on invested capital
93.65%
Total debt ratio
27.41%
Debt ratio change over time
-1.16%
Current Ratio
5.64%
Quick Ratio
5.64%
Cash Position Ratio
5.51%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-117.92%
Return on assets
-106.86%
Return on sales
-686.3%
Return on invested capital
-155.66%
Total debt ratio
-85.84%
Debt ratio change over time
-0.86%
Current Ratio
-1.8%
Quick Ratio
-1.8%
Cash Position Ratio
-1.78%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VYGR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -3.87% | 13.79% | 34.47% | 7.43% |
| Return on assets | -0.8% | 2.76% | 3.15% | 5.62% |
| Return on sales | -621.73% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 113.85% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 41% | 60% | 60% |
| Total debt ratio | 48.32% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.86% | 308.97% | -6.99% | 1.18% |
| Dept financing | 13% | 50% | 25% | 7% |
| Current Ratio | 5.26% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 5.26% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 4.8% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 10% | 22% | 52% |
| Short-term ratios | VYGR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -1.33% | 13.77% | 13.25% | 3.8% |
| Return on assets | -1.53% | 2.43% | 1.89% | 3.09% |
| Return on sales | -296.58% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 49.05% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 66% | 61% | 62% |
| Total debt ratio | 34.31% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.79% | 46.38% | -72.08% | 1.51% |
| Dept financing | 9% | 50% | 25% | 7% |
| Current Ratio | 5.26% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 5.26% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 4.8% | 0.36% | 1.28% | 2.93% |
| Liquididy | 74% | 10% | 25% | 62% |